MedTrace Logo

Fecal Immunochemical Test for Post-polypectomy Surveillance to Reduce Unnecessary eNdoscopy

NCT05396560 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 3000

Last updated 2022-05-31

No results posted yet for this study

Summary

This is an observational study in a clinical setting to estimate the prevalence of advanced colorectal neoplasia (ACN) at colonoscopy in those with a history of low or high risk polyps or a family history of CRC/polyps and to verify the test performance characteristics of FIT in these populations. Using this information, a risk prediction model will be developed to help guide the choice between FIT and colonoscopy in the ongoing surveillance or screening of patients.

Conditions

  • Colorectal Neoplasms

Sponsors & Collaborators

  • University of Calgary

    lead OTHER

Principal Investigators

  • Robert Hilsden, MD PhD · University of Calgary

Eligibility

Min Age
18 Years
Max Age
74 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-04-15
Primary Completion
2026-04-15
Completion
2027-04-15

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05396560 on ClinicalTrials.gov